Document:

EX-10.9

 Exhibit 10.9 

FORWARD PURCHASE AGREEMENT 

This Forward Purchase Agreement (this “Agreement”) is entered into as of ___________, by and between Hudson Executive
Investment Corp. III, a Delaware corporation (the “Company”), and HEC Master Fund LP, a Delaware limited partnership (the “Purchaser”). 

Recitals 
 WHEREAS,
the Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”);

 WHEREAS, the Company has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on
Form S-1, as amended (the “Registration Statement”), for its initial public offering (“IPO”) of 50,000,000 units (or 57,500,000 units if the underwriters’ over-allotment
option (the “IPO Option”) is exercised in full) (the “Public Units”) at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s Class A common stock, par value
$0.0001 per share (the “Class A Shares,” and the Class A Shares included in the Public Units, the “Public Shares”), and one-fifth of one redeemable
warrant, where each whole redeemable warrant is exercisable to purchase one Class A Share at an exercise price of $11.50 per share (the “Warrants,” and the Warrants included in the Public Units, the “Public
Warrants”); 
 WHEREAS, the Company’s sponsor, HEC Sponsor III LLC, has agreed to purchase an aggregate of 8,000,000 warrants
(or 9,000,000 warrants if the IPO Option is exercised in full) at a price of $1.50 per warrant in a private placement that will close simultaneously with the closing of the IPO (the “Private Placement Warrants”); 

WHEREAS, following the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business
Combination; 
 WHEREAS, the parties wish to enter into this Agreement, pursuant to which, concurrently with the closing of the
Company’s initial Business Combination (the “Business Combination Closing”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, on a private placement basis, the number of
units (the “Forward Purchase Units”) determined pursuant to Sections 1(a)(ii), (iii) and (iv) hereof, each comprised of one Class A Share (each, a “Forward Purchase
Share”) and one-fifth of one warrant (each, a “Forward Purchase Warrant”), on the terms and conditions set forth herein (the Forward Purchase Shares, the Forward Purchase Warrants
underlying the Forward Purchase Units and the Class A Shares underlying the Forward Purchase Warrants, the “Forward Purchase Securities”); 

WHEREAS, proceeds from the IPO and the sale of the Private Placement Warrants in an aggregate amount equal to the gross proceeds from the IPO
will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”), as described in the Registration Statement; and 

 WHEREAS, the amounts available to the Company from the Trust Account (after giving effect to
any redemptions of Public Shares) and any other equity or debt financing obtained by the Company in connection with the Business Combination (the “Available Cash”), together with the proceeds from the sale of the Forward Purchase
Units, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining amounts specified in the definitive agreement for the Business Combination (the
“Definitive Agreement”) to be retained for use by the post-Business Combination company for working capital or other purposes (the “Cash Requirements”); 

NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 

Agreement 
 1.
Sale and Purchase. 
 (a) Forward Purchase Units. 

(i) Subject to Sections 1(a)(ii), (iii) and (iv), the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, up to a maximum of 5,000,000 Forward Purchase Units (the “Maximum Units”) for a purchase price of $10.00 per Forward Purchase Unit (the “Forward Purchase Price”), or up to a maximum
of $50,000,000 in the aggregate. Each Forward Purchase Warrant will have the same terms as each Private Placement Warrant, and will be subject to the terms and conditions of the Warrant Agreement to be entered into between the Company and
Continental Stock Transfer & Trust Company, as Warrant Agent, in connection with the IPO, mutatis mutandis. 
 (ii) The
number of Forward Purchase Units to be issued and sold by the Company and purchased by the Purchaser hereunder shall be determined as follows: 

(A) As soon as reasonably practicable, but in no event less than ten (10) Business Days prior to the Company’s entry into the
Definitive Agreement, the Company shall provide the Purchaser with notice (the “Initial Company Notice”) of the number of Forward Purchase Units that it desires the Purchaser to purchase pursuant to this Agreement, which shall be
equal to its good faith estimate of that number which, after payment of the aggregate Forward Purchase Price by the Purchaser, will result in gross proceeds to the Company equal to the amount of funds necessary for the Company to satisfy the Cash
Requirements less the Available Cash; provided, however, that such number shall in no event exceed the Maximum Units; and provided, further, that, notwithstanding the foregoing, the Purchaser shall in any event
have the option to purchase up to the Maximum Units. Following delivery of the Initial Company Notice, the Company shall provide the Purchaser with such other information as the Purchaser (or any applicable Transferee pursuant to
Section 4(b) hereof) may reasonably request so that the Purchaser (or such Transferee) may seek the approval of its investment committee to consummate the purchase of the Forward Purchase Units hereunder. 

  
 2 

 (B) Within five (5) Business Days after receipt of the Initial Company Notice, the
Purchaser shall provide the Company with notice (the “Initial Purchaser Notice”) of the decision of its investment committee as to the number of Forward Purchase Units it wishes to purchase pursuant to this Agreement, if any, which
shall not exceed the Maximum Units, which notice shall constitute the binding obligation of the Purchaser to purchase such number of Forward Purchase Units, subject to the terms and conditions of this Agreement. 

(iii) At least two (2) Business Days before the Business Combination Closing, the Company shall provide the Purchaser with an updated
notice (the “Final Company Notice”) including: 
 (A) its determination, based on the actual number of Public Shares
validly submitted for redemption or other changes in the Cash Requirements, of the number of Forward Purchase Units that it desires the Purchaser to purchase pursuant to this Agreement; 

(B) the anticipated date of the Business Combination Closing; and 

(C) instructions for wiring the Forward Purchase Price. 

(iv) At least one (1) Business Day before the Business Combination Closing, the Purchaser shall provide the Company with an updated
notice (the “Final Purchaser Notice”) of the number of Forward Purchase Units it will be obligated to purchase pursuant to this Agreement, with no further notification or confirmation necessary from the Company, which number shall
not be less than the lesser of (A) the number of Forward Purchase Units that the Purchaser was obligated to purchase pursuant to Section 1(a)(ii) as indicated in the Initial Purchaser Notice and (B) the number of
Forward Purchase Units that the Company desires the Purchaser to purchase as specified in the Final Company Notice. 
 (v) The closing of
the sale of Forward Purchase Units (the “Forward Closing”) shall be held on the same date and concurrently with the Business Combination Closing (such date being referred to as the “Forward Closing Date”). At least
one (1) Business Day prior to the Forward Closing Date, the Purchaser shall deliver to the Company the Forward Purchase Price for the Forward Purchase Units by wire transfer of U.S. dollars in immediately available funds to the account
specified by the Company in such notice to be held in escrow until the Forward Closing. Immediately prior to the Forward Closing on the Forward Closing Date, (i) the Forward Purchase Price shall be released from escrow automatically and without
further action by the Company or the Purchaser, and (ii) upon such release, the Company shall issue the Forward Purchase Units to the Purchaser in book-entry form, free and clear of any liens or other restrictions whatsoever (other than those
arising under state or federal securities laws), registered in the name of the Purchaser (or its nominee in accordance with its delivery instructions), or to a custodian designated by the Purchaser, as applicable. In the event the Business
Combination Closing does not occur within five (5) Business Days of the date scheduled for closing, the Forward Closing shall not occur and the Company shall promptly (but not later than one (1 Business Day thereafter) return the Forward
Purchase Price to the Purchaser. For purposes of this Agreement, “Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions are generally authorized or required
by law or regulation to close or be closed in the City of New York, New York; provided, however, for clarification, commercial banks in the City of New York shall not be 

  
 3 

 
deemed to be authorized or required by law or regulation to close or be closed due to “stay at home”,
“shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of
any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in the City of New York are open for use by customers on such day. 

(b) Legends. Each register and book entry for the Forward Purchase Securities shall contain a notation, and each certificate (if any)
evidencing the Forward Purchase Securities shall be stamped or otherwise imprinted with a legend, in substantially the following form: 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY
STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS. THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN FORWARD PURCHASE
AGREEMENT BY AND BETWEEN THE HOLDER AND THE COMPANY. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.” 

2. Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as of the date
hereof: 
 (a) Organization and Power. The Purchaser is duly organized, validly existing, and in good standing under the laws of the
jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted. 

(b) Authorization. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered
by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies, or (iii) to the extent the indemnification provisions contained in the Registration Rights (as defined below) may be limited by applicable federal or state securities laws. 

(c) Governmental Consents and Filings. No consent, approval, order or authorization of, or registration, qualification, designation,
declaration or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the transactions contemplated by this Agreement. 

  
 4 

 (d) Compliance with Other Instruments. The execution, delivery and performance by the
Purchaser of this Agreement and the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions of its organizational documents, (ii) of any instrument,
judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to
which it is a party or by which it is bound or (v) of any provision of federal or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)),which would have a material adverse effect on the Purchaser or
its ability to consummate the transactions contemplated by this Agreement. 
 (e) Purchase Entirely for Own Account. This Agreement is
made with the Purchaser in reliance upon the Purchaser’s representation to the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Forward Purchase Securities to be acquired by the
Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of any state or federal securities laws, and that the
Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any
contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Forward Purchase Securities. For purposes of this Agreement,
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or any government or any department or agency thereof. 

(f) Disclosure of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial
affairs and the terms and conditions of the offering of the Forward Purchase Units, as well as the terms of the Company’s proposed IPO, with the Company’s management. 

(g) Restricted Securities. The Purchaser understands that the offer and sale of the Forward Purchase Units to the Purchaser has not
been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”), by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things,
the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the Forward Purchase Securities are “restricted securities” under applicable U.S.
federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Forward Purchase Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Forward Purchase Securities, or any Class A Shares into which the Forward Purchase Securities may
be converted or exercised, for resale, except for the Registration Rights. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not
limited to, the time and manner of sale, the holding period for the Forward Purchase Securities, and on requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may not
be able to satisfy. The Purchaser acknowledges that the Company filed the Registration Statement for its proposed IPO. The Purchaser understands that the offering of the Forward Purchase Securities is not, and is not intended to be, part of the IPO,
and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities Act with respect to the Forward Purchase Securities. 

  
 5 

 (h) No Public Market. The Purchaser understands that no public market now exists for
the Forward Purchase Securities, and that the Company has made no assurances that a public market will ever exist for the Forward Purchase Securities. 

(i) High Degree of Risk. The Purchaser understands that its agreement to purchase the Forward Purchase Securities involves a high degree
of risk which could cause the Purchaser to lose all or part of its investment. 
 (j) Accredited Investor. The Purchaser is an
accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. 
 (k) No General Solicitation.
Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (i) engaged in any general solicitation, or (ii) published any
advertisement in connection with the offer and sale of the Forward Purchase Units. 
 (l) Residence. The Purchaser’s principal
place of business is the office or offices located at the address of the Purchaser set forth on the signature page hereof. 
 (m) Non-Public Information. The Purchaser acknowledges its obligations under applicable securities laws with respect to the treatment of non-public information relating to the
Company. 
 (n) Adequacy of Financing. At the time of the Forward Closing, the Purchaser will have available to it sufficient funds to
satisfy its obligations under this Agreement. 
 (o) No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 2 and in any certificate or agreement delivered pursuant hereto, none of the
Purchaser nor any person acting on behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other express or implied representation or warranty with
respect to the Purchaser and this offering, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Company in Section 3 of this
Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Company, any person on behalf of
the Company or any of the Company’s affiliates (collectively, the “Company Parties”). 
 3. Representations
and Warranties of the Company. The Company represents and warrants to the Purchaser as follows: 
 (a) Incorporation and Corporate
Power. The Company is a corporation duly incorporated and validly existing and in good standing as a corporation under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as presently
conducted and as proposed to be conducted. The Company has no subsidiaries. 

  
 6 

 (b) Capitalization. On the date hereof, the authorized share capital of the Company
consists of: 
 (i) 380,000,000 Class A Shares, none of which are issued and outstanding. 

(ii) 20,000,000 shares of the Company’s Class B common stock, par value $0.0001 per shares (the “Class B
Shares”), 14,375,000 of which are issued and outstanding. All of the outstanding Class B Shares have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities
laws. 
 (iii) 1,000,000 preferred shares, none of which are issued and outstanding. 

(c) Authorization. All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to
authorize the Company to enter into this Agreement, and to issue the Forward Purchase Securities at the Forward Closing, and the securities issuable upon exercise of the Forward Purchase Warrants, has been taken or will be taken prior to the Forward
Closing. All action on the part of the stockholders, directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of the Company under this Agreement to be performed as of the
Forward Closing, and the issuance and delivery of the Forward Purchase Securities and the securities issuable upon exercise of the Forward Purchase Warrants has been taken or will be taken prior to the Forward Closing. This Agreement, when executed
and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies, or (iii) to the extent the indemnification provisions contained in the Registration Rights may be limited by applicable federal or state securities laws. 

(d) Valid Issuance of Securities. The Forward Purchase Securities, when issued, sold and delivered in accordance with the terms and for
the consideration set forth in this Agreement, and the securities issuable upon exercise of the Forward Purchase Warrants, when issued in accordance with the terms of the Forward Purchase Warrants and this Agreement, will be validly issued, fully
paid and nonassessable, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this
Agreement, applicable state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to the filings described in
Section 3(e) below, the Forward Purchase Securities will be issued in compliance with all applicable federal and state securities laws. 

  
 7 

 (e) Governmental Consents and Filings. Assuming the accuracy of the representations
and warranties made by the Purchaser in this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the
part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities Act, and applicable state securities laws, if any, and pursuant to the
Registration Rights. 
 (f) Compliance with Other Instruments. The execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions of the Company’s certificate of incorporation, as it may be amended from time to time (the
“Charter”), bylaws or other governing documents of the Company, (ii) of any instrument, judgment, order, writ or decree to which the Company is a party or by which it is bound, (iii) under any note, indenture or mortgage
to which the Company is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) of any provision of federal or state statute, rule or
regulation applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement. 

(g) Operations. As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any
operations other than organizational activities and activities in connection with offerings of its securities. 
 (h) No General
Solicitation. Neither the Company, nor any of its officers, directors, employees, agents or stockholders has either directly or indirectly, including, through a broker or finder (i) engaged in any general solicitation, or
(ii) published any advertisement in connection with the offer and sale of the Forward Purchase Units. 
 (i) No Other Representations
and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed
to make any other express or implied representation or warranty with respect to the Company, this offering, the proposed IPO or a potential Business Combination, and the Company Parties disclaim any such representation or warranty. Except for the
specific representations and warranties expressly made by the Purchaser in Section 2 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are relying upon any
other representations or warranties that may have been made by the Purchaser Parties. 
 4. Registration Rights; Transfer 

(a) Registration Rights. The Purchaser shall be granted registration rights by the Company with respect to the Forward Purchase
Securities pursuant to a registration rights agreement to be entered into with the Company, a form of which has been filed with the registration statement relating to the Company’s IPO (the “Registration Rights”). 

  
 8 

 (b) Transfer. This Agreement and all of the Purchaser’s rights and obligations
hereunder (including the Purchaser’s obligation to purchase the Forward Purchase Units) may be transferred or assigned, at any time and from time to time, in whole or in part, to one or more affiliates of the Purchaser (each such transferee, a
“Transferee”). Upon any such assignment: 
 (i) the applicable Transferee shall execute a signature page to this Agreement,
substantially in the form of the Purchaser’s signature page hereto (the “Joinder Agreement”), which shall reflect the number of Forward Purchase Units to be purchased by such Transferee (the “Transferee
Securities”), and, upon such execution, such Transferee shall have all the same rights and obligations of the Purchaser hereunder with respect to the Transferee Securities, and references herein to the “Purchaser” shall be
deemed to refer to and include any such Transferee with respect to such Transferee and to its Transferee Securities; provided, that any representations, warranties, covenants and agreements of the Purchaser and any such Transferee shall be
several and not joint and shall be made as to the Purchaser or any such Transferee, as applicable, as to itself only; and 
 (ii) upon a
Transferee’s execution and delivery of a Joinder Agreement, the number of Forward Purchase Units to be purchased by the Purchaser hereunder shall be reduced by the total number of Forward Purchase Units to be purchased by the applicable
Transferee pursuant to the applicable Joinder Agreement, which reduction shall be evidenced by the Purchaser and the Company amending Schedule A to this Agreement to reflect each transfer and updating the “Number of Forward Purchase
Units” and “Aggregate Purchase Price for Forward Purchase Units” on the Purchaser’s signature page hereto to reflect such reduced number of Forward Purchase Units, and the Purchaser shall be fully and unconditionally released
from its obligation to purchase such Transferee Securities hereunder. For the avoidance of doubt, this Agreement need not be amended and restated in its entirety, but only Schedule A and the Purchaser’s signature page hereto need be so
amended and updated and executed by each of the Purchaser and the Company upon the occurrence of any such transfer of Transferee Securities. 

5. Additional Agreements, Acknowledgements and Waivers of the Purchaser. 

(a) Lock-up; Transfer Restrictions. The Purchaser agrees that it shall not Transfer any Forward
Purchase Units (or the Forward Purchase Shares and Forward Purchase Warrants, including the Class A Shares issued or issuable upon the exercise of any such Forward Purchase Warrants) until 30 days after the completion of the initial Business
Combination. Notwithstanding the foregoing, Transfers of the Forward Purchase Units (and the underlying Class A Shares and Warrants, including the Class A Shares issued or issuable upon the exercise of any such warrants) are permitted (any
such transferees, the “Permitted Transferees”): (A) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the Purchaser, or any affiliates of
the Purchaser; (B) in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of individual’s immediate family or an affiliate of such person, or to a
charitable organization; (C) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (D) in the case of an individual, pursuant to a qualified domestic relations order; (E) by private
sales or transfers made in connection with the consummation of a Business Combination at prices no greater than the price at which the 

  
 9 

 
securities were originally purchased; (F) in the event of the Company’s liquidation prior to the completion of a Business Combination; (G) in the event of the Company’s
liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the Company’s stockholders having the right to exchange their Class A Shares for cash, securities or other property subsequent
to the completion of a Business Combination; (H) as a distribution to limited partners, members or stockholders of the Purchaser; (I) to the Purchaser’s affiliates, to any investment fund or other entity controlled or managed by the
Purchaser or any of its affiliates, or to any investment manager or investment advisor of the Purchaser or an affiliate of any such investment manager or investment advisor; (J) to a nominee or custodian of a person or entity to whom a
disposition or transfer would be permissible under clauses (A) through (I) above; (K) to the Purchaser or any Transferee hereunder; (L) by virtue of the laws of the Purchaser’s jurisdiction of formation or its organizational
documents upon dissolution of the Purchaser; and (M) pursuant to an order of a court or regulatory agency; provided, however, that in the case of clauses (A) through (E) and (H) through (L), these Permitted Transferees
must enter into a written agreement agreeing to be bound by these transfer restrictions. “Transfer” shall mean the (x) sale or assignment of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any
option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position (within the meaning of
Section 16 of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder) with respect to, any of the Forward Purchase Securities (excluding any pledges in the ordinary course of business for bona fide financing purposes
or as part of prime brokerage arrangements), (y) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Forward Purchase Securities, whether any such
transaction is to be settled by delivery of such Forward Purchase Securities, in cash or otherwise, or (z) public announcement of any intention to effect any transaction specified in clause (x) or (y). 

(b) Trust Account. 
 (i)
The Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account for the benefit of its public stockholders upon the IPO Closing. The Purchaser, for itself and its affiliates, hereby agrees that it has no right,
title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset of the Company as a result of any liquidation of the Company, except for redemption and liquidation rights, if any, the Purchaser may have in
respect of any Public Shares held by it. 
 (ii) The Purchaser hereby agrees that it shall have no right of
set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust
Account that it may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it. In the event the Purchaser has any Claim against the Company under this
Agreement, the Purchaser shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser
may have in respect of any Public Shares held by it. 

  
 10 

 6. Nasdaq Listing. The Company will use commercially reasonable efforts to effect the
listing of the Class A Shares and Public Warrants on The Nasdaq Capital Market (“Nasdaq”) (or another national securities exchange) at the time of the Business Combination Closing. 

7. Forward Closing Conditions. 

(a) The obligation of the Purchaser to purchase the Forward Purchase Units at the Forward Closing under this Agreement shall be subject to the
fulfillment, at or prior to the Forward Closing of each of the following conditions, any of which, to the extent permitted by applicable laws, may be waived by the Purchaser: 

(i) The Business Combination shall be consummated substantially concurrently with the purchase of the Forward Purchase Units; 

(ii) The Purchaser and any applicable Transferee shall have obtained the approval of its respective investment committee to consummate the
purchase of the Forward Purchase Units hereunder as contemplated by Section 1(a)(ii) hereof; 
 (iii) The Company
shall have delivered to the Purchaser a certificate evidencing the Company’s good standing as a Delaware corporation; 
 (iv) The
representations and warranties of the Company set forth in Section 3 of this Agreement shall have been true and correct as of the date hereof and shall be true and correct as of the Forward Closing Date, as applicable, with
the same effect as though such representations and warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified
date), except where the failure to be so true and correct would not have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement; 

(v) The Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Forward Closing; and 
 (vi) No order, writ,
judgment, injunction, decree, determination, or award shall have been entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or prohibition
shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Units. 
 (b) The obligation of the Company to sell the
Forward Purchase Units at the Forward Closing under this Agreement shall be subject to the fulfillment, at or prior to the Forward Closing of each of the following conditions, any of which, to the extent permitted by applicable laws, may be waived
by the Company: 
 (i) The Business Combination shall be consummated substantially concurrently with the purchase of Forward Purchase Units;

  
 11 

 (ii) The representations and warranties of the Purchaser set forth in
Section 2 of this Agreement shall have been true and correct as of the date hereof and shall be true and correct as of the Forward Closing Date, as applicable, with the same effect as though such representations and
warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and
correct would not have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement; 

(iii) The Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the Forward Closing; and 
 (iv) No
order, writ, judgment, injunction, decree, determination, or award shall have been entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or
prohibition shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Units. 
 8. Termination. This
Agreement may be terminated at any time prior to the Forward Closing: 
 (a) by mutual written consent of the Company and the Purchaser; 

(b) automatically 
 (i) if the
IPO is not consummated on or prior to twelve months from the date of this Agreement; or 
 (ii) if the Business Combination is not
consummated within 24 months from the closing of the IPO, or such later date as may be approved by the Company’s stockholders. 
 In
the event of any termination of this Agreement pursuant to this Section 8, the Forward Purchase Price (and interest thereon, if any), if previously paid, and all Purchaser’s funds paid in connection herewith shall be
promptly returned to the Purchaser, and thereafter this Agreement shall forthwith become null and void and have no effect, without any liability on the part of the Purchaser or the Company and their respective directors, officers, employees,
partners, managers, members, or stockholders and all rights and obligations of each party shall cease; provided, however, that nothing contained in this Section 8 shall relieve either party from liabilities or
damages arising out of any fraud or willful breach by such party of any of its representations, warranties, covenants or agreements contained in this Agreement. 

  
 12 

 9. General Provisions. 

(a) Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent
during normal business hours, then on the recipient’s next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) Business Day
after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: Hudson Executive Investment Corp.
III, 570 Lexington Avenue, 35th Floor, New York, New York 10022, Attn: Jonathan Dobres, Chief Financial Officer, email: jonathan.dobres@hudsonexecutive.com, with a copy to the Company’s counsel at: Milbank LLP, 55 Hudson Yards, New York,
New York 10001, Attn: Rod Miller, Esq., email: rdmiller@milbank.com. 
 All communications to the Purchaser shall be sent to the
Purchaser’s address as set forth on the signature page hereof, or to such e-mail address, facsimile number (if any) or address as subsequently modified by written notice given in accordance with this
Section 9(a). 
 (b) No Finder’s Fees. Each party represents that it neither is nor will be obligated
for any finder’s fee or commission in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s or broker’s
fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify
and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted
liability) for which the Company or any of its officers, employees or representatives is responsible. 
 (c) Survival of Representations
and Warranties. All of the representations and warranties contained herein shall survive the Forward Closing. 
 (d) Entire
Agreement. This Agreement, together with any documents, instruments and writings that are delivered pursuant hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter
and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. 

(e) Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon,
and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

(f) Assignments. Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its
rights, interests, or obligations hereunder without the prior written approval of the other party. 

  
 13 

 (g) Counterparts. This Agreement may be executed in two or more counterparts, each of
which will be deemed an original but all of which together will constitute one and the same instrument. 
 (h) Headings. The section
headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of this Agreement. 

(i) Governing Law. This Agreement, the entire relationship of the parties hereto, and any dispute between the parties (whether grounded
in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of laws principles. 

(j) Jurisdiction. The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of New York
and to the jurisdiction of the United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit,
action or other proceeding arising out of or based upon this Agreement except in state courts of New York or the United States District Court for the Southern District of New York, and (iii) hereby waive, and agree not to assert, by way of
motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit,
action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. 

(k) Waiver of Jury Trial. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this
Agreement and the transactions contemplated hereby. 
 (l) Amendments. This Agreement may not be amended, modified or waived as to any
particular provision except with the prior written consent of the Company and the Purchaser. 
 (m) Severability. The provisions of
this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof; provided, that if any provision of this Agreement, as applied to
any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making
such determination will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be enforceable and
will be enforced. 

  
 14 

 (n) Expenses. Each of the Company and the Purchaser will bear its own costs and
expenses incurred in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial advisors, legal
counsel and accountants. The Company shall be responsible for the fees of its transfer agent; stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Forward Purchase Securities and the securities issuable
upon conversion or exercise of the Forward Purchase Securities. 
 (o) Construction. The parties hereto have participated jointly in
the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or
disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine,
feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,”
“herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The
parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that
there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party
hereto is in breach of the first representation, warranty, or covenant. 
 (p) Waiver. No waiver by any party hereto of any default,
misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights
arising because of any prior or subsequent occurrence. 
 (q) Specific Performance. The Purchaser agrees that irreparable damage may
occur in the event any provision of this Agreement was not performed by the Purchaser in accordance with the terms hereof and that the Company shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or
equity. 
 [Signature Page Follows] 

  
 15 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as
of the date first set forth above. 
  

					
	PURCHASER:
	
	HEC MASTER FUND LP
		
		 	By: HEC Performance GP LLC,
		 	its General Partner
			
		 		 	By: HEC Management GP LLC,
		 		 	its Managing Member
		
	By:	 	  

	Name: Douglas L. Braunstein
	Title: Managing Member

  

			
	Address for Notices: 570 Lexington Avenue, 35th Floor
	New York, NY 10022
	
	E-mail: douglas.braunstein@hudsonexecutive.com
	
	COMPANY:
	
	HUDSON EXECUTIVE INVESTMENT CORP. III

			
		
	By:	 	  

			
	Name:	 	Jonathan Dobres
	Title:	 	Chief Financial Officer

 [Signature Page to Forward Purchase Agreement] 

 TO BE EXECUTED UPON ANY ASSIGNMENT AND/OR REVISION IN ACCORDANCE WITH THIS AGREEMENT TO “NUMBER OF
FORWARD PURCHASE UNITS” AND “AGGREGATE PURCHASE PRICE FOR FORWARD PURCHASE UNITS” SET FORTH BELOW 
  

							
	 Number of Forward Purchase Units:
	  				  	
	 Aggregate Purchase Price for Forward Purchase Units:
	  	$	 	 	  	
		  	  
	  

 Number of Forward Purchase Units and Aggregate Purchase Price for Forward Purchase Units as of , 202[ ], accepted and agreed
to as of this day of , 202[ ]. 
  

			
	[ ]
		
	By:	 	              

	Name:
	Title:
	
	HUDSON EXECUTIVE INVESTMENT CORP. III
		
	By:	 	          

	Name:
	Title:

 SCHEDULE A 

SCHEDULE OF TRANSFERS OF FORWARD PURCHASE UNITS 

The following transfers of a portion of the original number of Forward Purchase Units have been made: 

 

							
	 Date of Transfer
	 	 Transferee
	 	 Number of Forward

Purchase Units

Transferred
	  	 Purchaser Revised

Forward Purchase
 Units
Amount

  
 A-1 

 TO BE EXECUTED UPON ANY ASSIGNMENT OR FINAL DETERMINATION OF FORWARD PURCHASE UNITS: 

Schedule A as of , 202[ ], accepted and agreed to as of this day of , 202[ ] by: 
  

					
	[ ]	 	            	  	HUDSON EXECUTIVE INVESTMENT CORP. III
			
	By:                                     
                             	 		  	By:                                     
                              
	Name:
                                         
                 	 		  	Name:                                     
                         
	Title:                                     
                           	 		  	Title:
                                         
                     

  
 A-2Document

Exhibit 10.2

EMPLOYMENT AGREEMENT
AGREEMENT entered into as of December ___, 2020, by and between MEREDITH CORPORATION, an Iowa corporation (the “Company” or “Meredith”), and CATHERINE LEVENE (“Levene”), to be effective as of November 30, 2020 (“Effective Date”).
WITNESSETH:
WHEREAS, the Company wishes to employ Levene pursuant to the terms and conditions hereof, and in order to induce Levene to enter into this agreement (the “Agreement”) and to secure the benefits to accrue from her performance hereunder is willing to undertake the obligations assigned to it herein; and
WHEREAS, Levene is willing to be employed by the Company under the terms hereof and to enter into the Agreement.
NOW THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree as follows:
1.Position.
Meredith will employ Levene as President, National Media Group. While employed hereunder, Levene shall have the duties, responsibilities, powers, and authority customarily associated with the position of President, National Media Group.  Levene agrees to devote substantially all of her full time and attention and give her best efforts and skills to furthering the business and interests of the Company, which may include Levene volunteering her time and efforts, as reasonably requested, on behalf of charitable, civic, or professional organizations.  Levene shall not serve on the board of any other for-profit corporation or entity without the prior written authorization of the CEO of Meredith, except that nothing herein shall prohibit Levene from continuing to serve on the board of Business.com. 
2.Office Location.
Levene’s primary office location shall be at Meredith’s offices in New York, New York, but Levene shall make herself available at Meredith’s various offices as deemed necessary or appropriate by the CEO to meet Meredith’s business needs, upon reasonable notice.
3.Base Salary.
Levene’s minimum base salary under this Agreement will be Six Hundred Seventy-Five Thousand Dollars ($675,000) (“Base Salary”). Levene will be eligible for merit increases at the discretion of the Compensation Committee of the Company’s Board of Directors (“Compensation Committee”).  Base Salary shall include all such increased amounts, and Base Salary shall not be decreased.
    - 1 -

4.Incentive Plans.
4.1    While employed under this Agreement, Levene will continue to be eligible to participate in Meredith’s Annual Management Incentive Plan (or any successor or replacement annual incentive plan of Meredith) (“MIP”) for such periods as it continues in effect, subject to the terms of the MIP and to the discretion vested in the Compensation Committee of the Board  of Directors by the MIP.  As of the Effective Date, the percentage of Base Salary payable as a target bonus under the MIP shall not be less than eighty percent (80%) (actual Company financial results may eventuate in an actual bonus paid to Levene equal to, less than, or more than eighty percent (80%) of Base Salary). For the avoidance of doubt, in FY2021 any target bonus payout will be calculated at 50% of Base Salary from July 1 through the Effective Date and 80% of Base Salary from the Effective Date through June 30.  Any MIP payment will be paid out in August following the applicable Fiscal Year (the Company’s Fiscal Year runs from July 1 through June 30), and is conditioned on Levene’s active employment with Meredith at the end of the performance period (June 30) for the applicable Fiscal Year.  For sake of clarity, if Levene is actively employed with Meredith at the end of the applicable performance period, Levene shall receive any MIP payment regardless of whether Levene remains actively employed on the date of payment.
4.2    While employed under this Agreement, Levene will participate in an annual three-year Cash Long-Term Incentive Program (“Program” or “LTIP”), the first such Program shall be FY 22-24, in which she will have the opportunity to earn an additional cash payment of Two Hundred and Forty Thousand Dollars ($240,000) conditioned upon the achievement of certain specified financial objectives. Any payment under this Program will be made after the first regular August meeting of Meredith’s Board of Directors immediately following the conclusion of the three-year Program, subject to the terms of the Program and to the discretion vested in the Compensation Committee of the Board of Directors.
4.3    Levene is also currently participating in a three-year (FY 20-22) Cash Long-Term Incentive Program with a $100,000 target, conditioned upon the achievement of certain specified financial objectives. Under the Program, payment will made after the first regular August meeting of Meredith’s Board of Directors immediately following the conclusion of the three-year Program, subject to the terms of the Program and to the discretion vested in the Compensation Committee of the Board of Directors.  Levene is also currently participating in a three-year (FY 21-23) Cash Long-Term Incentive Program with a $100,000 target, conditioned upon the achievement of certain specified financial objectives. Under the Program, payment will made after the first regular August meeting of Meredith’s Board of Directors immediately following the conclusion of the three-year Program, subject to the terms of the Program and to the discretion vested in the Compensation Committee of the Board of Directors.
4.4    While employed under this Agreement, Levene will continue to be eligible to participate in Meredith’s 2014 Stock Incentive Plan (the “Plan”) for such periods as it continues in effect.  Each fiscal year, beginning in August 2021, Levene will be eligible for an annual grant of non-qualified stock options and restricted stock units, which annual grant shall have an estimated total value of at least Three Hundred Sixty Thousand Dollars ($360,000), three-year cliff vest, subject to the terms of the Plan and to the discretion and approval of the Compensation Committee of the Board of Directors.  In addition, Meredith will recommend that Levene receive 
    - 2 -

a special, one-time, promotion equity grant of non-qualified stock options and restricted stock units with an estimated total value or $180,000, subject to the terms of the Plan and to the discretion and approval of the Compensation Committee of the Board of Directors at the January 2021 Board of Directors meeting.
4.5    While employed under this Agreement, Levene will be eligible to participate in in Meredith’s Supplemental Benefit Plan for such periods as it continues in effect, subject to the terms of the Plan.
4.6    Levene acknowledges and agrees that she shall be subject to Meredith Corporation’s Incentive Compensation Clawback Policy or any successor or replacement clawback policy for such periods as it continues in effect.  Meredith agrees that any successor or replacement to the Incentive Compensation Clawback Policy shall have no greater adverse effect on Levene than on all other similarly situated executives.
5.Perquisites and Short-Term Disability.  
    5.1    Perquisites. During her employment under this Agreement, Levene shall receive or be eligible to participate in, to the extent permitted by law, the various perquisites and plans generally available to officers of Meredith, in accordance with the provisions thereof as in effect from time to time, including, without limitation, professional fee reimbursement for tax preparation and financial planning, supplemental executive life insurance, executive long term disability insurance, the Meredith Supplemental Benefit Plan, the Amended and Restated Severance Agreement Between Meredith Corporation and Executive Officers, and a minimum of four (4) weeks of vacation per year. Levene will similarly be provided with an automobile allowance of $11,050/year under Meredith’s executive automobile allowance policy and reimbursement for the initiation fees and regular dues in a country club in the New York, New York area, subject to Meredith policy and applicable withholding and deductions. Furthermore, Levene will be entitled to reimbursement, in accordance with Meredith policy, for reasonable expenses incurred in connection with the performance of her duties with Meredith, provided Levene properly accounts therefor. 
    5.2    Short-Term Disability.  During any period of short-term disability, the Company will continue to pay Levene the Base Salary throughout the period of short-term disability, up to a maximum of six (6) months of Base Salary payments pursuant to this Section 5.2. In addition, Levene will continue to receive all rights and benefits under the benefit plans and programs of the Company in which Levene is a participant, as determined in accordance with the terms of such plans and programs, and Levene shall be eligible to receive the benefit of her MIP target bonus for the initial year in which the short-term disability occurs without reduction for the period of the short-term disability. In the event of Levene's death during a period of short-term disability, the provisions of Section 6.5 shall apply. For purposes of this Agreement, short-term disability shall be defined as the incapacitation of Levene by reason of sickness, accident or other physical or mental disability for a period of time. All benefits provided under this Section 5.2 shall be in replacement of and not in addition to benefits payable under the Company’s short-term and long-term disability plans, except to the extent that such disability plans provide greater benefits than the disability benefits provided under this Agreement, in which case the disability plans would supersede the applicable provisions of this Agreement. In the event Levene is 
    - 3 -

determined to have a long-term disability (as described in Section 6.4), the provisions of Section 6.4 shall apply.
6.Termination of Employment.
6.1    Termination for Cause. This Agreement and Levene’s employment hereunder may be terminated by Meredith at any time for “Cause,” in which case Levene will receive only her Base Salary through the date of such termination. Upon such termination, Levene shall be entitled to no further benefits under this Agreement, except that any rights and benefits Levene may have under the employee benefit plans and programs of the Company, in which Levene is a participant, shall be determined in accordance with the terms and provisions of such plans and programs. Levene understands and agrees that in the event of the termination of employment and termination of this Agreement pursuant to this Section 6.1, all awards of restricted stock units, stock options and any other benefits under the Incentive Plans shall be handled in accordance with the terms of the relevant plan and agreements entered into between Levene and the Company with respect to such awards, but that the obligations of Levene under Section 7 shall remain in full force and effect. “Cause” is defined as (i) the willful and continued failure of Levene to attempt to perform substantially her duties with the Company (other than any such failure resulting from disability), after a demand for substantial performance is delivered to Levene, which specifically identifies the manner in which Levene has not attempted to substantially perform her duties and for those matters which are subject to cure, a ten (10) day notice to cure is provided or (ii) the engaging by Levene in willful misconduct which is materially injurious to the Company, monetarily or otherwise. For purposes of this definition, no act, or failure to act, on the part of Levene shall be considered “willful” unless it is done, or omitted to be done, by Levene in bad faith and without reasonable belief that Levene’s act or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Company’s Board of Directors or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Levene in good faith and in the best interests of the Company. Under no circumstances will Levene be entitled to more than three (3) ten (10) day notice to cure periods during Levene’s employment with Meredith.    
6.2    Termination Without Cause. This Agreement and Levene’s employment hereunder may be terminated by Meredith at any time without Cause and without prior notice. In the event Levene’s employment is terminated without Cause by Meredith, then in return for a signed separation agreement that includes a full release of all employment-related claims (it being understood that the separation agreement will not impose on Levene any additional restrictive covenants or other post-employment restrictions in excess of those contained in Section 7 of this Agreement), Levene will receive the following: (a) her Base Salary, minus applicable withholding and deductions, through the date on which notice is given; (b) separation payments equivalent to her regular biweekly Base Salary, minus applicable withholding and deductions, for a period of eighteen (18) months following the date of notice to her; (c) a lump sum payment equal to her annual Management Incentive Plan target bonus, minus applicable withholding and deductions, pro-rated for the year in which such termination occurs through the date on which notice of termination is given; (d) a lump-sum payment equal to 1.5 times her MIP target bonus, minus applicable withholding and deductions; and (e) COBRA subsidy benefits as and to the extent set forth in Section 2.4(b) of the Meredith Corporation Severance Pay Plan in 
    - 4 -

effect as of the Effective Date. If Levene does not execute the above-mentioned release, Levene will receive only her Base Salary through the date on which notice of termination is given. It is understood that if as a result of Levene’s termination without Cause hereunder Levene could qualify for a severance payment under the Meredith Corporation Severance Pay Plan or the Amended and Restated Severance Agreement Between Meredith Corporation and Executive Officers, Levene may be treated under either this Agreement or one of the above referenced plans, whichever provides the greater compensation to Levene, as determined by Levene, but Levene is not entitled to receive the consideration provided for under this Agreement and any of the above referenced plans under any circumstances. 
Upon such termination, Levene shall be entitled to no further benefits under this Agreement, except that any rights and benefits Levene may have under the employee benefit plans and programs of the Company, in which Levene is a participant, shall be determined in accordance with the terms and provisions of such plans and programs. 
6.3    Employee Voluntary. In the event Levene terminates her employment of her own volition, except for a termination described in Section 6.6, such termination shall constitute a voluntary termination and in such event Meredith’s only obligation to Levene shall be to make Base Salary payments provided for in this Agreement through the date of such voluntary termination. Any rights and benefits Levene may have under the employee benefit plans and programs of the Company, in which she is a participant, shall be determined in accordance with the terms and provisions of such plans and programs. All awards of restricted stock, restricted stock units, stock options and any other benefits under the Incentive Plans shall be handled in accordance with the terms of the relevant plan and agreements entered into between Levene and the Company with respect to such awards.
6.4    Employee Disability. If Levene shall be determined to have a Long-Term Disability (as defined below), then the employment of Levene hereunder and this Agreement may be terminated by Levene or the Company upon thirty (30) days’ written notice to the other party following such determination. After the thirty (30)-day written notice is provided, Levene’s employment shall end and the Company shall pay to Levene, at such times as Base Salary would normally be paid, one hundred percent (100%) of Base Salary for the first twelve (12) months following said termination, seventy-five percent (75%) of the Base Salary for the next twelve (12)-month period, and fifty percent (50%) of Base Salary for the final twelve (12)-month period. Furthermore, nothing contained in this Section 6.4 shall preclude Levene from receiving the benefit of her MIP target bonus for the initial year in which a short-term disability occurs pursuant to the provisions of Section 5.2. Following the termination pursuant to this Section 6.4, the Company shall pay or provide Levene such other rights and benefits of participation under the employee benefit plans and programs of the Company to the extent that such continued participation is not otherwise prohibited by applicable law or by the express terms and provisions of such plans and programs. All benefits provided under this Section 6.4 shall be in replacement of and not in addition to benefits payable under the Company’s short-term and long-term disability plans, except to the extent that such disability plans provide greater benefits than the disability benefits provided under this Agreement, in which case the applicable disability plans(s) would supersede the applicable provisions of this Agreement. All awards of restricted stock, restricted stock units, stock options and any other benefits under the Incentive Plans shall be handled in accordance with terms of the relevant plan and agreements entered into between 
    - 5 -

Levene and the Company with respect such awards. For purposes of this Section 6.4, Long-Term Disability shall be defined and determined pursuant to the terms of the long-term disability plan in effect for employees of the Company, and if no such plan exists, then Long-Term Disability shall be defined consistent with the definition of disability set forth in Section 409A of the Code.
6.5    Employee Death.  In the event Levene’s employment ends due to her death, this Agreement shall terminate and all obligations to Levene shall cease as of the date of death, except that the Company will pay to the legal representative of her estate in substantially equal installments the Base Salary until the end of the month of the first anniversary of Levene's death. Any annual MIP bonus (or amounts in lieu thereof), payable for the fiscal year in which Levene’s death occurs, shall be determined by the Compensation Committee at its meeting following the end of such fiscal year, pro-rated to the date of death, and promptly paid to Levene’s estate. All rights and benefits of Levene under the benefit plans and programs of the Company in which Levene is a participant, will be provided as determined in accordance with the terms and provisions of such plans and programs. All awards of restricted stock units, stock options and any other benefits under the Incentive Plans shall be handled in accordance with terms of the relevant plan and agreements entered into between Levene and the Company with respect such awards
6.6    Change in Title, Duties Location, or Compensation. If at any time during Levene’s employment with the Company under the terms of this Agreement (a) a change is made to Levene’s title as President, National Media Group, (b) there is a material change in Levene having at least the same level of responsibility and authority associated with being President, National Media Group as she has on date this Agreement is executed, (c) an involuntary change is made to the location of Levene’s principal office more than twenty-five (25) miles from the New York, New York area, or (d) Meredith makes an involuntary reduction in Levene’s Base Salary or target annual Management Incentive Plan bonus opportunity, Levene shall have the right to terminate her employment with the Company by giving written notice within ninety (90) days after the date of Levene receiving written notice of such action, and the Company shall have a period of thirty (30) days to cure such action, and, if the Company does not cure, such termination shall be deemed to be Termination Without Cause by the Company and such termination shall be treated in accordance with the terms of Section 6.2.  
6.7    Officers and Directors Insurance. The Company agrees to maintain Levene’s coverage under such directors’ and officers’ liability insurance policies as shall from time to time be in effect for active officers and employees for not less than six (6) years following Levene’s termination of employment.
7.Covenants of Levene.
7.1    Levene acknowledges that as a result of the services to be rendered to the Company hereunder, Levene will be brought into close contact with many confidential affairs of the Company, its subsidiaries and affiliates, not readily available to the public. Levene further acknowledges that the services to be performed under this Agreement are of a special, unique, unusual, extraordinary and intellectual character; that the business of the Company is international in scope; that its goods and services are marketed throughout the United States and 
    - 6 -

various parts of the world and that the Company competes with other organizations that are or could be located in nearly any part of the United States and in various parts of the world.
7.2    In recognition of the foregoing, Levene covenants and agrees that, except as is necessary in providing services under this Agreement or to the extent necessary to comply with law or the valid order of a court or government agency of competent jurisdiction, Levene will not knowingly use for her own benefit nor knowingly divulge any Confidential Information and Trade Secrets of the Company, its subsidiaries and affiliated entities, which are not otherwise in the public domain and, so long as they remain Confidential Information and Trade Secrets not in the public domain, will not intentionally disclose them to anyone outside of the Company either during or after her employment. For the purposes of this Agreement, "Confidential Information and Trade Secrets" of the Company means information which is secret to the Company, its subsidiaries and affiliated entities. It may include, but is not limited to, information relating to the magazines, books, publications, products, services, television stations, real estate franchise operations, new and future concepts and business of the Company, its subsidiaries and affiliates, in the form of memoranda, reports, computer software and data banks, customer lists, employee lists, books, records, financial statements, manuals, papers, contracts and strategic plans. As a guide, Levene is to consider information originated, owned, controlled or possessed by the Company, its subsidiaries or affiliated entities which is not disclosed in printed publications stated to be available for distribution outside the Company, its subsidiaries and affiliated entities as being secret and confidential. In instances where doubt does or should reasonably be understood to exist in Levene's mind as to whether information is secret and confidential to the Company, its subsidiaries and affiliated entities, Levene agrees to request an opinion, in writing, from the Company.  Notwithstanding the above, 
(a)    Levene understands that she has immunity from criminal or civil liability for disclosure of a trade secret: (1) made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; or (2) made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (3) in a lawsuit against Meredith for retaliation for reporting a suspected violation of law, Levene may disclose a trade secret to her attorney and use the trade secret information in the court proceeding, if Levene files under seal any document containing the trade secret, and does not disclose the trade secret except pursuant to court order. 
(b)    Nothing in this Section 7.2 prohibits Levene from reporting possible violations of law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal law or regulation.
(c)    Levene shall disclose to the public and discuss such information as is customary or legally required to be disclosed by a Company whose stock is publicly traded, or that is otherwise legally required to disclose, or that is in the best interests of the Company to do so.
(d)    Levene will deliver promptly to the Company on the termination of her employment with the Company, or at any other time the Company may so request, all 
    - 7 -

memoranda, notes, records, reports and other documents relating to the Company, its subsidiaries and affiliated entities, and all property owned by the Company, its subsidiaries and affiliated entities, which Levene obtained while employed by the Company, and which Levene may then possess or have under her control.
7.3    Levene agrees that during her employment with Meredith and, provided any applicable termination payments have been paid pursuant to Section 6, for a period of eighteen (18) months after her employment ends (whether her employment is ended voluntarily or involuntarily by Levene or Meredith), Levene will not, directly or indirectly, whether as a sole proprietor, partner, venture, stockholder, director, officer, employee, consultant, or in any other capacity as a principal or agent or through any person, subsidiary, affiliate, or employee acting as nominee or agent, engage in any of the following activities:
(a)    Knowingly interfere with, disrupt or attempt to disrupt, any then existing relationship, contractual or otherwise, between the Company, its subsidiaries or affiliated entities, and any customer, client, supplier, or agent;
(b)    Hire, solicit or attempt to hire or solicit any person who is employed by Meredith or attempt to influence any such person to terminate employment with Meredith (for the avoidance of doubt, this provision shall in no way prohibit job postings of general applicability, provided they are not specifically targeted at employees of the Company); or
(c)    Render services directly or indirectly as an employee, officer, director, consultant, independent contractor or in any other capacity to, conduct or engage in any activities for the benefit of, or be interested in or associated with, any of the entities listed on Exhibit A hereto (“Competitor”), or take any action to finance or guarantee or knowingly to provide other material assistance to any Competitor.
7.4    Levene will promptly disclose to the Company all inventions, processes, original works of authorship, trademarks, patents, improvements and discoveries related to the business of the Company, its subsidiaries and affiliated entities (collectively "Developments"), conceived or developed during Levene's employment with the Company and based upon information to which she had access during the term of employment, whether or not conceived during regular working hours, through the use of the Company time, material or facilities or otherwise. All such Developments shall be the sole and exclusive property of the Company, and upon request Levene shall deliver to the Company all outlines, descriptions and other data and records relating to such Developments, and shall execute any documents deemed necessary by the Company to protect the Company's rights hereunder. Levene agrees upon request to assist the Company to obtain United States or foreign letters patent and copyright registrations covering inventions and original works of authorship belonging to the Company hereunder. If the Company is unable because of Levene's mental or physical incapacity to secure Levene's signature to apply for or to pursue any application for any United States or foreign letters patent or copyright registrations covering inventions and original works of authorship belonging to the Company hereunder, then Levene hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as her agent and attorney in fact, to act for and in her behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution 
    - 8 -

and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by  her . Levene hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever, that she may hereafter have for infringement of any patents or copyright resulting from any such application for letters patent or copyright registrations belonging to the Company hereunder.
7.5    Levene agrees to cooperate with Meredith in the truthful and honest prosecution and/or defense of any claim in which Meredith may have an interest (with the right of reimbursement for reasonable expenses actually incurred) which may include, without limitation, being available to participate in any proceeding involving Meredith, permitting interviews with representatives of Meredith, appearing for depositions and trial testimony, and producing and/or providing any documents or names of other persons with relevant information in Levene’s possession or control arising out of her employment in a reasonable time, place and manner.
7.6    Levene agrees that the remedy at law for any breach or threatened breach of any covenant contained in this Section 7 may be inadequate and that the Company, in addition to such other remedies as may be available to it, in law or in equity, shall be entitled to injunctive relief without bond or other security.
7.7    Although the restrictions contained in Section 7 are considered by the parties hereto to be fair and reasonable in the circumstances, it is recognized that restrictions of such nature may fail for technical reasons, and accordingly it is hereby agreed that if any of such restrictions shall be adjudged to be void or unenforceable for whatever reason, but would be valid if part of the wording thereof were deleted, or the period thereof reduced or the area dealt with thereby reduced in scope, the restrictions contained in Section 7 shall be enforced to the maximum extent permitted by law, and the parties consent and agree that such scope or wording may be accordingly judicially modified in any proceeding brought to enforce such restrictions.
7.8    Notwithstanding that Levene's employment hereunder may be terminated as provided in Section 6 above, this Agreement shall continue in full force and effect insofar as is necessary to enforce the covenants and agreements of Levene contained in this Section 7.
8.Arbitration.
8.1    The parties shall use their best efforts and good will to settle all disputes by amicable negotiations. The Company and Levene agree that, with the express exception of any dispute or controversy arising under Section 7 of this Agreement or under any distinct severance or benefit plan or program with its own, express dispute resolution provisions, any controversy or claim arising out of or in any way relating to Levene’s employment with the Company, including, without limitation, any and all disputes concerning this Agreement and the termination of this Agreement that are not amicably resolved by negotiation, shall be settled by arbitration in Des Moines, Iowa, or such other place agreed to by the parties, as follows:
(a)    An arbitration may be commenced by any party to this Agreement by the service of a written Request for Arbitration upon the other affected party. Such Request for Arbitration shall summarize the controversy or claim to be arbitrated. No Request for Arbitration shall be valid if it relates to a claim, dispute, disagreement or controversy that 
    - 9 -

would have been time barred under the applicable statute of limitations had such claim, dispute, disagreement or controversy been submitted to the courts of Iowa.
(b)    The arbitration will be conducted before an impartial arbitrator appointed as follows. Within sixty (60) days of the Request for Arbitration the parties shall  mutually agree to an arbitrator. If the parties fail to mutually agree to an arbitrator within sixty (60) days, then within seventy-five (75) days following Request for Arbitration, each party shall produce to the other a list of three (3) potential arbitrators. Within ninety (90) days of the Request for Arbitration the parties will meet in person or by conference call to select an arbitrator from the combined list. Each party will first strike two (2) names from the other party’s list. The arbitrator will then be selected by lot from the two potential arbitrators whose names have not been stricken. The parties will evenly split the costs of the arbitrator. Legal fees and costs may be awarded by the arbitrator in accordance with applicable law.
(c)    Judgment on the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.
(d)    It is intended that controversies or claims submitted to arbitration under this Section 8 shall remain confidential, and to that end it is agreed by the parties that neither the facts disclosed in the arbitration, the issues arbitrated, nor the views or opinions of any persons concerning them, shall be disclosed by third persons at any time, except to the extent necessary to enforce an award or judgment or as required by law or in response to legal process or in connection with such arbitration. In addition, Levene and the Company shall be entitled to disclose the facts disclosed in arbitration, the issues arbitrated, and the views or opinions of any persons concerning them to legal and tax advisors so long as such advisors agree to be bound by the terms of this Agreement.
9.Governing Law.
This Agreement shall be deemed a contract made under, and for all purposes shall be construed in accordance with, the laws of the State of Iowa without reference to the principles of conflict of laws.
10.  Entire Agreement; Modification; Waiver.

This Agreement, and those plans and agreements referenced herein contain all the understandings and representations between Levene and Meredith pertaining to Levene’s employment with Meredith and supersede all other negotiations, discussions, correspondence, communications, understandings, and agreements between the parties relating to the subject matter of this Agreement. This Agreement may be modified only in writing signed by Levene and an authorized representative of Meredith. Except as otherwise specifically provided in this Agreement, no waiver by either party hereto of any breach by the other party of any condition or                     provision of the Agreement to be performed by such other party shall be deemed a waiver of a similar or dissimilar provision or condition at the same or any prior or subsequent time.
    - 10 -

11.  Headings. 
Headings of the sections of this Agreement are intended solely for convenience and no provision of this Agreement is to be construed by reference to the title of any section.
12.  Severability. 
In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions or portions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.
13. Withholding.
Anything to the contrary notwithstanding, all payments required to be made by the Company hereunder to Levene or her beneficiaries, shall be subject to withholding and deductions as the Company may reasonably determine it should withhold or deduct pursuant to any applicable law or regulation. In lieu of withholding or deducting, such amounts, in whole or in part, the Company may, in its sole discretion, accept other provision for payment as permitted by law, provided it is satisfied in its sole discretion that all requirements of law affecting its responsibilities to withhold such taxes have been satisfied.
14.  Section 409A.  
    This Agreement is intended to be interpreted and operated to the fullest extent possible so that the payments and benefits under this Agreement either shall be exempt from the requirements of Section 409A of the Code or, to the extent such payments are not exempt from Section 409A of the Code, such payments and benefits shall be interpreted and operated to comply with the requirements of Section 409A of the Code.  Payments payable under this Agreement triggered by a termination of employment that are deferred compensation subject to (but not otherwise exempt from) Section 409A of the Code shall not be made unless such termination of employment constitutes a separation from service within the meaning of Section 409A of the Code.  Notwithstanding any other provision in this Agreement to the contrary, if Levene is a “specified employee” on the date of her separation from service within the meaning of Section 409A of the Code and Treasury Regulation 1.409A-1(h), payments and benefits payable under this Agreement due to a separation from service that are deferred compensation subject to (but not otherwise exempt from) Section 409A of the Code that would otherwise be paid or provided during the six-month period commencing on the separation from service, will be deferred until the first day of the seventh month following the separation from service if such deferral is necessary to avoid the additional tax under Section 409A of the Code.  In the case of a series of payments, the first payment shall include the amounts Levene would have been entitled to receive during the six-month waiting period.  Each payment made under this Agreement shall be designated as a “separate payment” within the meaning of Section 409A of the Code.  If the period during which Levene has discretion to execute or revoke the separation agreement described in Section 6.2 straddles two calendar years, the cash severance or other benefits shall be paid or commence being paid, as applicable, as soon as practicable in the second of the two calendar years, regardless of within which calendar year Levene actually delivers the executed 
    - 11 -

separation agreement to the Company, subject to the separation agreement first becoming effective.  Consistent with section 409A of the Code, Levene may not, directly or indirectly, designate the calendar year of payment. Notwithstanding anything contained in this Agreement to the contrary, if any payment made pursuant to this Agreement is a substitute or replacement for a right to payment that constitutes nonqualified deferred compensation within the meaning of Section 409A of the Code, including, to the extent applicable, amounts payable under another plan or agreement between Levene and the Company or its subsidiaries, parents and affiliated entities, then any such payment amount shall be paid at the time and in the form as required by Section 409A of the Code.
To the extent required by Section 409A of the Code, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance with the following: (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year; (ii) any reimbursement of an eligible expense shall be paid to Levene on or before the last day of the calendar year following the calendar year in which the expense was incurred; and (iii) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.
15. Section 280G.  
If any portion of the payments or benefits under this Agreement, or under any other agreement with Levene or plan of the Company or its affiliates (in the aggregate, “Total Payments,” and each a “Payment”), would constitute an “excess parachute payment” and would, but for this Section 16, result in the imposition on Levene of an excise tax (the “Excise Tax”) under Section 4999 of the Code, then, to the extent reasonably practicable and permitted by applicable law, the Total Payments to be made to Levene shall either be (i) delivered in full, or (ii) delivered in such amount so that no portion of such Total Payments would be subject to the Excise Tax, whichever of the foregoing results in the receipt by Levene of the greatest benefit on an after-tax basis (taking into account the applicable federal, state and local income taxes and the Excise Tax). The determination required by this Section 16 shall be made by the Company in its reasonable determination and in reliance on its tax advisors. The reduction of the amounts payable under this Agreement, if applicable, shall be made by reducing taxable Payments before non-taxable Payments, and Payments nearest in time before Payments later in time, unless an alternative method of reduction is elected by Levene to the extent consistent with Section 409A of the Code. For purposes of reducing the Total Payments, only amounts payable under this Agreement (and no other Payments) shall be reduced.
16. Successors and Assigns.
16.1    Assignment by the Company.  This Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of the Company.
16.2    Assignment by Levene.  Levene may not assign this Agreement or any part thereof; provided, however, that nothing herein shall preclude one or more beneficiaries of Levene from receiving any amount that may be payable following the occurrence of Levene’s legal incompetency or her death and shall not preclude the legal representative of her estate from 
    - 12 -

receiving such amount or from assigning any right hereunder to the person or persons entitled thereto under her will or, in the case of intestacy, to the person or persons entitled thereto under the laws of the intestacy applicable to her estate.
17.  Notices.
Any notice to be given hereunder shall be in writing and delivered personally or sent by overnight mail, such as Federal Express, addressed to the party concerned at the address indicated below or to such other address as such party may subsequently give notice of  hereunder in writing:

If to Company:

Meredith Corporation 
Dina Nathanson, Senior Vice President, Human Resources
1716 Locust Street
Des Moines, Iowa 50309-3023

with a copy to:

Meredith Corporation
Legal Department
1716 Locust Street
Des Moines, Iowa 50309-3023

If to Levene:

Catherine Levene
President, National Media Group
150 Jackson Ave 
Pelham, NY 10803

with a copy to (which shall not constitute notice):

    Brad Schwartzberg
    Davis & Gilbert LLP
    1675 Broadway
    New York, New York 10019

18. Knowledge and Representation.
Levene acknowledges that the terms of this Agreement have been fully explained to  her, that Levene understands the nature and extent of the rights and obligations provided under this Agreement, and that Levene has been afforded an adequate opportunity to be represented by legal counsel in the negotiation and preparation of this Agreement.
    - 13 -

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first set forth above.
									
	MEREDITH CORPORATION

By:  Dina Nathanson

                    
Dated:          
		CATHERINE LEVENE

                    
Dated:          

			
	By:  Dina Nathanson		
	/s/ Dina Nathanson		/s/ Catherine Levene
	Dated:      12/1/2020     
		Dated:      12/1/2020     

    - 14 -

Exhibit A
•Amazon
•Apple
•Buzzfeed
•Conde Nast/Advance
•Discovery/Scripps Network
•Facebook
•Google
•Hearst
•IAC
•NBC Universal
•Refinery 29
•Snap, Inc.
•New York Times
•Verizon/Oath
•Vox Media

    - 15 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]